Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Study Conducted to Evaluate the Performance of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care Sites

NCT05728970 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.

NCT NCT05728970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05728970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Study Conducted to Evaluate the Performance of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care Sites
Lead sponsor
LumiraDx UK Limited
Phase
Observational
Overall status
Completed
Start date
February 9, 2023
Completion date
April 11, 2023
Enrollment
716 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza a, influenza b, sars-cov-2